NVOH vs. IPOS
NVOH (Novo Nordisk A/S (B Shares) ADRhedged ETF) and IPOS (Renaissance International IPO ETF) are both Foreign Large Cap Equities funds. NVOH is actively managed, while IPOS is passively managed. Over the past year, NVOH returned -16.84% vs 48.80% for IPOS. At a 0.18 correlation, their price movements are largely independent. NVOH charges 0.19%/yr vs 0.80%/yr for IPOS.
Performance
NVOH vs. IPOS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVOH achieves a 4.29% return, which is significantly lower than IPOS's 33.99% return.
NVOH
- 1D
- -1.96%
- 1M
- 15.70%
- 6M
- -15.26%
- YTD
- 4.29%
- 1Y
- -16.84%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IPOS
- 1D
- -2.71%
- 1M
- -7.93%
- 6M
- 22.32%
- YTD
- 33.99%
- 1Y
- 48.80%
- 3Y*
- 14.17%
- 5Y*
- -8.08%
- 10Y*
- 2.76%
NVOH vs. IPOS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | 4.29% | -43.79% |
IPOS Renaissance International IPO ETF | 33.99% | 36.79% |
Correlation
The correlation between NVOH and IPOS is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jan 7, 2025 | 0.18 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVOH vs. IPOS — Risk / Return Rank
NVOH
IPOS
NVOH vs. IPOS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) and Renaissance International IPO ETF (IPOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVOH | IPOS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.80 | ||
| Sortino ratioReturn per unit of downside risk | -2.15 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.27 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.37 | 2.86 | -3.22 |
| Martin ratioReturn relative to average drawdown | -0.57 | 8.12 | -8.69 |
Loading charts...
Drawdowns
NVOH vs. IPOS - Drawdown Comparison
The maximum NVOH drawdown since its inception was -61.60%, smaller than the maximum IPOS drawdown of -73.09%. Use the drawdown chart below to compare losses from any high point for NVOH and IPOS.
Loading charts...
Drawdown Indicators
| NVOH | IPOS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.60% | -73.09% | +11.49% |
Max Drawdown (1Y)Largest decline over 1 year | -46.22% | -17.17% | -29.05% |
Max Drawdown (3Y)Largest decline over 3 years | — | -34.08% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -69.21% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -73.09% | — |
Current DrawdownCurrent decline from peak | -45.12% | -43.06% | -2.06% |
Average DrawdownAverage peak-to-trough decline | -39.05% | -32.05% | -7.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.81% | 6.03% | +23.78% |
Volatility
NVOH vs. IPOS - Volatility Comparison
The current volatility for Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) is 9.21%, while Renaissance International IPO ETF (IPOS) has a volatility of 11.79%. This indicates that NVOH experiences smaller price fluctuations and is considered to be less risky than IPOS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVOH | IPOS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.21% | 11.79% | -2.58% |
Volatility (6M)Calculated over the trailing 6-month period | 35.79% | 31.06% | +4.73% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.29% | 33.73% | +15.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.04% | 28.16% | +19.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 48.04% | 24.52% | +23.52% |
NVOH vs. IPOS - Expense Ratio Comparison
NVOH has a 0.19% expense ratio, which is lower than IPOS's 0.80% expense ratio.
Dividends
NVOH vs. IPOS - Dividend Comparison
NVOH's dividend yield for the trailing twelve months is around 6.20%, more than IPOS's 0.35% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPOS Renaissance International IPO ETF | 0.35% | 1.04% | 0.93% | 0.33% | 0.00% | 0.00% | 0.25% | 0.89% | 1.12% | 0.87% | 1.73% | 1.08% |
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | 6.20% | 2.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
NVOH and IPOS have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IPOS has higher volatility (11.79%) compared to NVOH (9.21%). In terms of maximum drawdown, NVOH dropped -61.60% vs IPOS's -73.09%.
On 1-year performance, IPOS leads with 48.80% vs -16.84% for NVOH. On fees, NVOH is cheaper at 0.19% per year. On volatility, NVOH has been the lower-risk option at 9.21%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IPOS has performed better with a 48.80% return vs -16.84%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NVOH is cheaper with a 0.19% expense ratio, compared with 0.80% for IPOS.
NVOH has the higher dividend yield at 6.20%, compared with 0.35% for IPOS.
They also come from different issuers: Precidian and Renaissance Capital. Their fees differ too: 0.19% for NVOH and 0.80% for IPOS.
IPOS currently has the higher Sharpe Ratio (1.45 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVOH and IPOS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer